EP300 and Rubinstein-Taybi syndrome: To determine the functional impact of impaired CBP and EP300 activities on the levels of the HSF2 protein in this pathological context, we first compared the amounts of HSF2 protein in cells derived from either healthy donors (HD) or RSTS patients carrying mutations or deletions either in the CBP or EP300 genes (Fig. 6a; Methods).